Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Armata Pharmaceuticals (ARMP) EBT Margin (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed EBT Margin for 6 consecutive years, with 339.81% as the latest value for Q4 2018.

  • Quarterly EBT Margin fell 2393019.0% to 339.81% in Q4 2018 from the year-ago period, while the trailing twelve-month figure was 1106.8% through Dec 2018, up 723549.0% year-over-year, with the annual reading at 455.45% for FY2025, 49961.0% down from the prior year.
  • EBT Margin hit 339.81% in Q4 2018 for Armata Pharmaceuticals, down from 902.61% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 24270.0% in Q4 2017 to a low of 27725.0% in Q2 2017.
  • Historically, EBT Margin has averaged 4160.28% across 5 years, with a median of 2645.1% in 2015.
  • Biggest five-year swings in EBT Margin: skyrocketed 7325469bps in 2014 and later tumbled -2398617bps in 2017.
  • Year by year, EBT Margin stood at 2571.29% in 2014, then rose by 11bps to 2296.88% in 2015, then plummeted by -632bps to 16809.09% in 2016, then soared by 244bps to 24270.0% in 2017, then plummeted by -99bps to 339.81% in 2018.
  • Business Quant data shows EBT Margin for ARMP at 339.81% in Q4 2018, 902.61% in Q3 2018, and 1127.05% in Q2 2018.